Clinical
Explore Aiforia’s comprehensive portfolio of high-performance AI solutions, engineered for both clinical and preclinical applications. Aiforia’s solutions aim to enhance the speed, accuracy, and consistency of analyzing large and complex medical images, especially in pathology.
Learn moreResearch
Aiforia’s research solutions offer fully automated study-centric workflows and pathology image analysis applications that cater to all research areas. Empowered by robust AI capabilities, pathologists and scientists can make discoveries while saving time by automating repetitive tasks – also within the framework of GLP. Aiforia’s solutions can be integrated with any existing laboratory infrastructure to enjoy the full benefits of a digitized workflow.
Learn moreAiforia® Create is the most versatile tool for developing deep learning AI models for image analysis in digital pathology. Its cloud-based, collaborative working environment allows multiple users to work together in real time, anywhere in the world. Praised for its intuitive user interface, it allows users a fast start, even without any prior AI experience.Learn more >
Learn moreExplore Aiforia’s comprehensive portfolio of high-performance AI solutions, engineered for both clinical and preclinical applications. Aiforia’s solutions aim to enhance the speed, accuracy, and consistency of analyzing large and complex medical images, especially in pathology.
Learn moreAI development tool
Aiforia® Create is the most versatile tool for developing deep learning AI models for image analysis in digital pathology. Its cloud-based, collaborative working environment allows multiple users to work together in real time, anywhere in the world. Praised for its intuitive user interface, it allows users a fast start, even without any prior AI experience.
Learn moreResources
Explore some of our latest publications showcasing the discoveries enabled by the Aiforia® Platform.
Learn moreAiforia's insights and resources for AI in pathology. View some of our content pieces from the world of AI.
Learn moreStay updated with Aiforia’s recent announcements. Explore our latest news, updates and announcements.
Learn moreCompany
Find out more about shareholder matters, investment discussions, and financial-related information.
Learn moreAiforia's mission is to transform pathology image analysis with AI, enabling better care for each patient. To succeed, we need our trusted partners. Explore Aiforia’s partner network.
Learn moreExperience our AI solutions firsthand. Explore the list of conferences where you can connect with Aiforia’s team live and book a time to discover the future of AI-powered image analysis.
Learn moreOur mission is to transform pathology image analysis with AI, enabling better care for each patient. Find out more about job openings, thesis opportunities, or submitting applications.
Learn moreAiforia Technologies holds information security to the highest standard. We hold several, globally relevant quality and security certifications, so you can be sure your sensitive information is safe.
Learn moreClinical
Clinical Solutions
AI solutions portfolio
Research
AI development tool
Aiforia® Create
Resources
Company
About us
Investors
Partners
Media
Events
Careers
Quality and security
Neuroscientists Fredric Manfredsson and Ivette Sandoval, both currently at the Barrow Neurological Institute, had never considered using deep learning AI. Their research on gene therapies for Parkinson’s disease felt far connected to artificial intelligence.
However, after meeting an Aiforia scientist at a conference, they were intrigued by the potential of this software as a tool to challenge current methods of neuron quantification with stereology, an extremely time-consuming part of their lab’s work. This alternative tool was met with some hesitation at first, as Fredric mentions: “I was skeptical that a computer or software could figure out this analysis.”
The two scientists embarked upon their first experimentation with deep learning AI. “The Aiforia methods and stats were impressive. The results produced were comparable to what we would get with our traditional methods using stereology,” Fredric describes. “When the best technician in the lab did this analysis, compared to Aiforia, the relative difference in results produced was very small.” Aiforia, therefore, provided promising, comparable results, assuaging the scientists’ skepticism.
What impressed Fredric and Ivette even more was the speed at which this analysis was conducted: “With a computer technician interface, it takes a couple of hours per animal.” Therefore, with the 3,000 sections analyzed as part of this scope of work, Ivette explains:
“It would have taken 20 workdays with stereology. Aiforia did this in a few days.”
When asked how they both felt about deep learning AI now, both replied: “We turned from skeptics to believers.”
Automating this once time-consuming analysis grants scientists and the rest of their lab significantly more time to focus on complex tasks. Hours were spent training PhD students, who would then spend many hours counting these cells. As a PhD student left the lab, another one would have to be trained.
Subjectivity can arise between counters, resulting in the potential for further issues. “The field is set on traditional ways of counting; it takes up so much time. I was excited the Aiforia software was validated,” Fredric adds. Both neuroscientists, now self-proclaimed believers, are excited to explore other ways in which deep learning can enhance their research.
Read more neuro case studies: